UK hypertension treatment guidelines consider ethnicity (Black or non-Black) as a determinant of treatment choice. However, evidence from randomised controlled trials of the effectiveness and risks of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in different ethnic groups is lacking. Using primary care data from self-reported Black, South Asian, and White patients at high risk of cardiovascular disease in England, Paris J. Baptise and colleagues apply reference trial emulation methods to assess the ‘real-world’ generalisability of results from the ONTARGET trial to trial-underrepresented groups.
Image Credit: Joanna Zduńczyk, Pexels
Perspective
Is C-reactive protein sufficient to guide antimicrobial therapy for lower respiratory tract infections among children? Results from a stepped-wedge cluster randomized trial in Uganda
PLOS Medicine: published September 17, 2024 | https://doi.org/10.1371/journal.pmed.1004467
Related Articles
Research Articles
A comprehensive assessment of care competence and maternal experience of first antenatal care visits in Mexico: Insights from the baseline survey of an observational cohort study
PLOS Medicine: published September 3, 2024 | https://doi.org/10.1371/journal.pmed.1004456
Effects of a self-guided digital mental health self-help intervention for Syrian refugees in Egypt: A pragmatic randomized controlled trial
PLOS Medicine: published September 9, 2024 | https://doi.org/10.1371/journal.pmed.1004460
Association between surgeon training grade and the risk of revision following unicompartmental knee replacement: An analysis of National Joint Registry data
PLOS Medicine: published September 10, 2024 | https://doi.org/10.1371/journal.pmed.1004445
Associations between food insecurity in high-income countries and pregnancy outcomes: A systematic review and meta-analysis
PLOS Medicine: published September 10, 2024 | https://doi.org/10.1371/journal.pmed.1004450
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
PLOS Medicine: published September 12, 2024 | https://doi.org/10.1371/journal.pmed.1004428
The cost-effectiveness of preventing, diagnosing, and treating postpartum haemorrhage: A systematic review of economic evaluations
PLOS Medicine: published September 13, 2024 | https://doi.org/10.1371/journal.pmed.1004461
Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data
PLOS Medicine: published September 16, 2024 | https://doi.org/10.1371/journal.pmed.1004465
HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort
PLOS Medicine: published September 16, 2024 | https://doi.org/10.1371/journal.pmed.1004452
Impact on beer sales of removing the pint serving size: An A-B-A reversal trial in pubs, bars, and restaurants in England
PLOS Medicine: published September 17, 2024 | https://doi.org/10.1371/journal.pmed.1004442
Behavioral risk factors and socioeconomic inequalities in ischemic heart disease mortality in the United States: A causal mediation analysis using record linkage data
PLOS Medicine: published September 17, 2024 | https://doi.org/10.1371/journal.pmed.1004455
Development, characterization, and replication of proteomic aging clocks: Analysis of 2 population-based cohorts
PLOS Medicine: published September 24, 2024 | https://doi.org/10.1371/journal.pmed.1004464
Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia
PLOS Medicine: published September 26, 2024 | https://doi.org/10.1371/journal.pmed.1004397
Correction
Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
PLOS Medicine: published September 16, 2024 | https://doi.org/10.1371/journal.pmed.1004470